Return to home page
Searching: Muskingum library catalog
Some OPAL libraries remain closed or are operating at reduced service levels. Materials from those libraries may not be requestable; requested items may take longer to arrive. Note that pickup procedures may differ between libraries. Please contact your library for new procedures, specific requests, or other assistance.
Record 1 of 6
  Previous Record Previous Item Next Item Next Record
 
COMPUTER FILE
Title Guidance for industry : amendment (donor deferral for transfusion in France since 1980) to "Guidance for industry, revised preventive measures to reduce the possible risk of transmission of Creutzfeldt-Jakob disease (CJD) and variant Creutzfeldt-Jakob disease (vCJD) by blood and blood products"
Imprint Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research, [2006]

LOCATION CALL # STATUS MESSAGE
 ONLINE GOVERNMENT PUBLICATION  HE 20.4802:D 71/3    ONLINE  
Subject Creutzfeldt-Jakob disease -- United States -- Prevention.
Blood -- Transfusion -- Government policy -- United States.
Blood products -- Government policy -- United States.
Alt Name Center for Biologics Evaluation and Research (U.S.)
Add Title Amendment (donor deferral for transfusion in France since 1980) to "Guidance for industry, revised preventive measures to reduce the possible risk of transmission of Creutzfeldt-Jakob disease (CJD) and variant Creutzfeldt-Jakob disease (vCJD) by blood and blood products"
Revised preventive measures to reduce the possible risk of transmission of Creutzfeldt-Jakob disease (CJD) and variant Creutzfeldt-Jakob disease (vDJD) by blood and blood products
LOCATION CALL # STATUS MESSAGE
 ONLINE GOVERNMENT PUBLICATION  HE 20.4802:D 71/3    ONLINE  
Subject Creutzfeldt-Jakob disease -- United States -- Prevention.
Blood -- Transfusion -- Government policy -- United States.
Blood products -- Government policy -- United States.
Alt Name Center for Biologics Evaluation and Research (U.S.)
Add Title Amendment (donor deferral for transfusion in France since 1980) to "Guidance for industry, revised preventive measures to reduce the possible risk of transmission of Creutzfeldt-Jakob disease (CJD) and variant Creutzfeldt-Jakob disease (vCJD) by blood and blood products"
Revised preventive measures to reduce the possible risk of transmission of Creutzfeldt-Jakob disease (CJD) and variant Creutzfeldt-Jakob disease (vDJD) by blood and blood products
Description i, 4 pages : digital, PDF file
monochrome rdacc
System Details Mode of access: Internet at the FDA CBER web site. Address as of 5/18/09: http://www.fda.gov/cber/gdlns/cjdfrance.pdf ; current access is available via PURL.
Note Title from PDF title page (viewed on May 18, 2009).
"Draft guidance."
"August 2006".
Bibliography Note Includes bibliographical references (p. 4).
OCLC # 325125165


If you experience difficulty accessing or navigating this content, please contact the OPAL Support Team